• Experienced Team in Providing New Therapeutic Options for Doctors

    Know More

  • Driving for the Advancement of Medicine

    Know More

  • Transformative Treatment through Revolutionary Technology

    Know More

About Spectrix Therapeutics

Spectrix Therapeutics, LLC is a privately-held specialty pharmaceutical company committed to transforming how disorders, such as hypothyroidism, are treated pharmacologically. Our therapies will redefine how patients cope with those disorders and improve quality of life.

Know More

Technology

Our technologies utilize ion exchange resin to form a drug resin complex. The drug is first dissolved in a solution removing variability due to crystalline structure.

Know More

Clinical Studies

Spectrix clinical studies will be based on 505(b)(2) NDA regulatory pathway leveraging prior clinical data to greatly reduce time and cost.

Know More

Newswire

Spectrix will attend the ATA’s 89th Annual Meeting in Chicago this October. To schedule a meeting with Spectrix during this conference, please contact Sara Rice at srice@spectrixtx.com

Know More